简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2014-03-12 17:34 STC life, Co., Ltd. Successfully Treats Canadian Pulmonary Fibrosis Patient at 97.7 B&H Hospital Stem Cell Center
2014-03-12 17:18 Quintiles Honored as ‘Best CRO in Asia’ for 3rd Time in Four Years
2014-03-11 17:43 Quintiles Announces Launch of Secondary Public Offering of Common Stock
2014-03-11 17:12 ResearchDx, the Leading Contract Diagnostics Organization, Sponsors the Asia BioPharma Convention 2014
2014-03-11 10:38 22nd Century Group Subsidiary Goodrich Tobacco Company Granted Federal Permit to Manufacture Tobacco Products
2014-03-07 16:20 SecondOpinions.com Releases Innovative Mobile Application to Android and Apple Stores Featuring Patent Pending Automated Algorithm to Assess & Predict Risk of Disease
2014-03-07 16:15 22nd Century Group Approved to List Common Stock on NYSE MKT
2014-03-07 15:09 Independent Study Shows V.A.C. VeraFlo™ Therapy More Beneficial Than Traditional V.A.C.® Therapy
2014-03-06 14:40 Pathway Genomics Acquires First Illumina NextSeq 500 Next-Generation Sequencing Systems
2014-03-05 11:54 Beltone Launches Beltone First, a Revolutionary Hearing Aid
2014-03-05 10:28 Harlan Contract Research Services (CRS) and Bertin Pharma Announce Strategic Collaboration
2014-03-04 14:56 Australian Owned, KISMET JARDIN Wins Prestigious IAIR Global Award for Innovation and Sustainability
2014-03-04 11:03 STC life, Ltd. Successfully Treats Stroke Patients at Stem Cell Research Treatment Center
2014-03-03 15:57 On the Day World Recognizes 350m Rare Disease Sufferers, Quintiles Publishes Insights in Tackling the Challenges
2014-02-28 18:18 Covidien Completes Acquisition of Given Imaging
2014-02-26 13:24 Toshiba Starts Sample Shipments of Low Power Consumption ICs for Bluetooth® Smart Devices
2014-02-26 13:11 Pathway Genomics Acquires FDA-Cleared Illumina MiSeqDx Next-Generation Sequencing Systems
2014-02-26 13:02 Focus on Asia Medical Cosmetology Congress 2014
2014-02-26 12:53 4th China Vaccine Focus 2014
2014-02-26 11:40 SCYNEXIS Receives Qualified Infectious Disease Product (QIDP) Designation from the FDA for Antifungal Agent SCY-078 for Oral Use

Business Wire Weibo

Press Releases

Latest Releases